3TC150mg+AZT300mg tabs/PAC-60

Lamivudine 150mg + Zidovudine 300mg film coated tablets, bottle or blister pack of 60
Indicative Price : Upon Request
Disclaimer: The images shown are for illustration purposes only and may not be an exact representation of the product. “No Generic Photo Available" means that there is not an image available for this product.

NOTE: The description below is for a standard product. It is not specific to patent status and pricing policies that may apply at country level. This information is available on request from Supply Division: Contact: supply@unicef.org

General Description:
Lamivudine 150mg + Zidovudine 300mg film coated tablets, pack of 60

Technical Specifications:
Each film coated tablet contains Lamivudine 150mg and Zidovudine 300mg.

Therapeutic class:
Nucleoside Reverse Transcriptase Inhibitors (NRTI)

Standard shelf life:
3 years

Other available formulations:
The product may also be available in other formulations, pack sizes, or in combinations with other ARVs.

Guidelines for use:
For more details, please click the links listed below:

WHO treatment guidelines


WHO Essential Medicines Library

or your regional national guidelines

For details about paediatric dosage schemes, please click the links listed below:


WHO Generic tool for assessing paediatric ARV dosing

Management of HIV infection in children and adults in combination with Nevirapine. By mouth (oral), PO.
PMTCT: In combination with other drugs for prevention of mother-to child HIV transmission.

Do not store above 30°C (86°F).
Store in tightly closed original container
Keep out of reach and sight of children

Dispensing instructions:
Dispense in original container. Do not repack

Regulatory status:
For latest updates, please click the links listed below:

List of WHO Prequalified Medicines

List of USFDA approved and tentatively approved items

Further information:
Component of a kit
(S1400523) is a component of S9901003- IEHK 2011 PEP Kit
Related Products